| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 2.772 | 36.419 | 25.559 | 27.896 | 42.687 | 52.099 | 63.227 |
| Total Income - EUR | - | - | - | 2.772 | 36.419 | 26.132 | 27.896 | 42.687 | 52.100 | 63.272 |
| Total Expenses - EUR | - | - | - | 757 | 8.978 | 9.816 | 12.276 | 13.015 | 19.613 | 24.354 |
| Gross Profit/Loss - EUR | - | - | - | 2.015 | 27.440 | 16.316 | 15.620 | 29.672 | 32.487 | 38.918 |
| Net Profit/Loss - EUR | - | - | - | 1.987 | 27.076 | 16.070 | 15.375 | 29.252 | 31.976 | 37.059 |
| Employees | - | - | - | 1 | 1 | 1 | 1 | 1 | 2 | 2 |
Check the financial reports for the company - Neuroped Plus S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 419 | 266 | 118 | 0 | 392 | 1.394 |
| Current Assets | - | - | - | 2.226 | 27.120 | 8.443 | 15.598 | 29.723 | 32.111 | 36.598 |
| Inventories | - | - | - | 32 | 557 | 640 | 680 | 1.132 | 2.682 | 3.447 |
| Receivables | - | - | - | 0 | 20.605 | 7.684 | 9.738 | 24.593 | 29.297 | 26.532 |
| Cash | - | - | - | 2.194 | 5.957 | 119 | 5.180 | 3.998 | 131 | 6.619 |
| Shareholders Funds | - | - | - | 2.030 | 27.118 | 7.742 | 15.431 | 29.292 | 31.985 | 37.100 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 196 | 420 | 967 | 286 | 430 | 518 | 892 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Neuroped Plus S.r.l.